Bone Marrow News and Research

RSS

Bone Marrow is the soft, sponge-like tissue in the center of most bones. It produces white blood cells, red blood cells, and platelets.

Researchers identify active stem cells in “resting zone” of cartilage

Researchers have discovered active chondrocytes within cartilage. The finding could help scientists understand bone abnormalities.

31 Oct 2018

Researchers examine immune responses to CRISPR-Cas9 gene editing system

The CRISPR-Cas9 gene editing system has been generating excitement within the field of gene therapy, inspiring hopes of molecular tools capable of treating genetic diseases.

30 Oct 2018

Ischemia-induced stem cells can be promising candidates for CNS injury therapeutics

Researchers have performed a careful comparison between locally generated, ischemia-induced, multipotent stem cells and bone marrow-derived mesenchymal stem cells in an effort to determine which cell type has greater central nervous system repair capacity.

26 Oct 2018

EU-funded project addresses important bottleneck in the field of tissue engineering

There is a shortage of donor tissue for grafting procedures to replace damaged human tissue. Tissue engineering holds great promise for generating tissue, but clinical success has been limited because the resulting tissue fails to integrate in the patient’s body after transplantation.

25 Oct 2018

Scientists identify new target for battling deadly form of leukemia

UT Southwestern scientists, working with colleagues at a sister institution in Houston, have identified a new target for battling a deadly form of leukemia.

24 Oct 2018

MIT researchers devise way to help blood cells regenerate after radiation therapy

Patients with blood cancers such as leukemia and lymphoma are often treated by irradiating their bone marrow to destroy the diseased cells. After the treatment, patients are vulnerable to infection and fatigue until new blood cells grow back.

24 Oct 2018

Drugs approved for breast cancer treatment are effective and well tolerated in men

There is growing evidence that drugs approved for the treatment of breast cancer in women are also effective and well tolerated in men, according to the largest real-life study yet to investigate treatment and outcomes in men with breast cancer and two further studies to be reported at ESMO 2018.

23 Oct 2018

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

A new program project grant from the National Cancer Institute will fund research by the Translational Center of Excellence for Lung Cancer Immunology at the Abramson Cancer Center of the University of Pennsylvania to improve the effectiveness of chimeric antigen receptor T cell therapy at fighting solid tumors.

23 Oct 2018

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

Researchers from The Ottawa Hospital and the University of Ottawa have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia and a diagnostic test to determine which AML patients would most likely benefit from this treatment.

22 Oct 2018

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.

22 Oct 2018

Newly developed synthetic DNA molecule may one day be used as 'vaccine' for prostate cancer

Researchers from City of Hope, a world-renowned comprehensive cancer center and independent biomedical research institution, have developed a synthetic DNA molecule that is programmed to jump-start the immune system to eradicate genetically distinct types of prostate cancer.

19 Oct 2018

The immune system also plays a key role in day-to-day function of healthy organs

The cells of the immune system sustain life by infiltrating infected and dmaged tissue and eliminating pathogenic microorganisms and cell debris.

19 Oct 2018

UC researcher focuses on light-mediated therapies to target breast cancer

When treatment is working for a patient who is fighting cancer, the light at the end of the tunnel is easier to see.

17 Oct 2018

Study suggests new approach to treat life-threatening blood disorder in children

Pediatric researchers studying the life-threatening blood disorder Fanconi anemia have devised a method to block the abnormal biological signals that drive the disease.

12 Oct 2018

Cornell dots equipped with antibody fragments offer a new cancer weapon

Antibody-based imaging of a particularly aggressive form of breast cancer is undergoing clinical trials worldwide, but the path from trial to application is being hampered by a major obstacle: safety.

12 Oct 2018

Eight promising biomedical research projects receive ASH Bridge Grants

Today, ASH announced the names of eight investigators who have each been awarded $150,000 through the ASH Bridge Grant Program.

12 Oct 2018

New hope for children with aggressive form of cancer

Children with an aggressive form of cancer are being given new hope in a world-first trans-Atlantic clinical trial that will test a new three-part treatment.

10 Oct 2018

Researchers receive DoD grant to test efficacy of stem cell therapy for eye injuries

Researchers at the University of Illinois at Chicago have received a four-year, $5.25 million grant from the U.S. Department of Defense to lead a multi-site clinical trial to test the efficacy of a stem cell-based treatment for eye injuries.

5 Oct 2018

Researchers caution that expediting HLH treatment may miss underlying cancers

Physicians who specialize in a devastating and aggressive immune disorder called hemophagocytic lymphohistiocytosis report in a new study that extra care should be taken to ensure an HLH diagnosis doesn't obscure possible underlying cancers.

1 Oct 2018

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

Adaptive Biotechnologies today announced that Blood, the Journal of the American Society of Hematology, published online an analysis of patient samples from the Intergroupe Francophone du Myéloma 2009 trial.

1 Oct 2018

Bone Marrow News and Research

Further Reading

Researchers identify active stem cells in “resting zone” of cartilage

Researchers examine immune responses to CRISPR-Cas9 gene editing system

Ischemia-induced stem cells can be promising candidates for CNS injury therapeutics

EU-funded project addresses important bottleneck in the field of tissue engineering

Scientists identify new target for battling deadly form of leukemia

MIT researchers devise way to help blood cells regenerate after radiation therapy

Drugs approved for breast cancer treatment are effective and well tolerated in men

NCI grant awarded to Abramson Cancer Center to study CAR T cells In solid tumors

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Newly developed synthetic DNA molecule may one day be used as 'vaccine' for prostate cancer

The immune system also plays a key role in day-to-day function of healthy organs

UC researcher focuses on light-mediated therapies to target breast cancer

Study suggests new approach to treat life-threatening blood disorder in children

Cornell dots equipped with antibody fragments offer a new cancer weapon

Eight promising biomedical research projects receive ASH Bridge Grants

New hope for children with aggressive form of cancer

Researchers receive DoD grant to test efficacy of stem cell therapy for eye injuries

Researchers caution that expediting HLH treatment may miss underlying cancers

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News